During the past decade, Pharmacy Department conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pharmacy Department" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Pharmacy Department" are "Advanced, Androgen Receptor Positive Triple Negative Breast Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Pharmacy Department" in a lesser frequency.

Most popular intervention types in "Pharmacy Department" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (2 trials), "Placebo (for enzalutamide)" (1 trials) and "exemestane" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pharmacy Department" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Pharmacy Department". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Pharmacy Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pharmacy Department, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".